Steve Kalloger
Overview
Explore the profile of Steve Kalloger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
912
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ali H, Karasinska J, Topham J, Johal D, Kalloger S, Metcalfe A, et al.
Cancer Metab
. 2024 Oct;
12(1):28.
PMID: 39363341
Background: Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive disease characterized by complex metabolic rewiring that enables growth in changing nutrient availability and oxygen conditions. Transcriptome-based prognostic PDAC tumor subtypes,...
2.
Kanter F, Lellmann J, Thiele H, Kalloger S, Schaeffer D, Wellmann A, et al.
Cancers (Basel)
. 2023 Feb;
15(3).
PMID: 36765644
Despite numerous diagnostic and therapeutic advances, pancreatic ductal adenocarcinoma (PDAC) has a high mortality rate, and is the fourth leading cause of cancer death in developing countries. Besides its increasing...
3.
Karamitopoulou E, Esposito I, Zlobec I, Cacciato Insilla A, Wartenberg M, Schaeffer D, et al.
Virchows Arch
. 2020 Dec;
478(4):719-726.
PMID: 33330964
Tumor budding has been reported to be an independent prognostic factor in pancreatic ductal adenocarcinoma (PDAC). Its use in daily diagnostics would improve the prognostic stratification of patients. We performed...
4.
Tessier-Cloutier B, Schaeffer D, Bacani J, Marginean C, Kalloger S, Kobel M, et al.
Histopathology
. 2020 May;
77(1):46-54.
PMID: 32413172
Aims: Undifferentiated carcinoma refers to an epithelial malignancy that lacks morphological evidence of differentiation. Recent studies have implicated the loss of constitutively expressed switch/sucrose non-fermenting (SWI/SNF) complex subunits in undifferentiated...
5.
Pollard S, Kalloger S, Weymann D, Sun S, Nuk J, Schrader K, et al.
Health Expect
. 2020 Apr;
23(4):884-892.
PMID: 32338425
Background: Multi-gene panel testing is replacing single-gene testing for patients with suspected hereditary cancer syndromes. The detection of a hereditary cancer syndrome allows tested individuals to initiate enhanced primary and...
6.
Cremin C, Lee M, Hong Q, Hoeschen C, Mackenzie A, Dixon K, et al.
Cancer Med
. 2020 Apr;
9(11):4004-4013.
PMID: 32255556
Background: Recent guidelines recommend consideration of germline testing for all newly diagnosed pancreatic ductal adenocarcinoma (PDAC). The primary aim of this study was to determine the burden of hereditary cancer...
7.
Ziada A, Lu M, Ignas-Menzies J, Paintsil E, Li M, Ogbuagu O, et al.
Aging Cell
. 2019 Aug;
18(6):e13018.
PMID: 31407474
The gradual accumulation of mitochondrial DNA (mtDNA) mutations is implicated in aging and may contribute to the accelerated aging phenotype seen with tobacco smoking and HIV infection. mtDNA mutations are...
8.
Todorovic E, Sheffield B, Kalloger S, Walker B, Wiseman S
Cureus
. 2018 May;
10(3):e2348.
PMID: 29796360
Background: The objective of this study was to determine if patient age and/or gender significantly alter the risk of thyroid malignancy in the Bethesda System for Reporting Thyroid Cytopathology (BSRTC)...
9.
McKenney J, Gilks C, Kalloger S, Longacre T
Am J Surg Pathol
. 2016 Jul;
40(9):1155-64.
PMID: 27428735
The classification of extraovarian disease into invasive and noninvasive implants predicts patient outcome in patients with high-stage ovarian serous borderline tumors (tumors of low malignant potential). However, the morphologic criteria...
10.
McPherson A, Roth A, Laks E, Masud T, Bashashati A, Zhang A, et al.
Nat Genet
. 2016 May;
48(7):758-67.
PMID: 27182968
We performed phylogenetic analysis of high-grade serous ovarian cancers (68 samples from seven patients), identifying constituent clones and quantifying their relative abundances at multiple intraperitoneal sites. Through whole-genome and single-nucleus...